Why CYP450 Variants Belong in Every Pre-Op Checklist
CYP2D6 poor metabolizers face serious adverse drug reactions from standard opioid dosing. Here is why the evidence compels action and what perioperative teams can do now.
Clinical, operational, and regulatory perspectives for teams evaluating modern perioperative intelligence.
CYP2D6 poor metabolizers face serious adverse drug reactions from standard opioid dosing. Here is why the evidence compels action and what perioperative teams can do now.
At $15,000 to $65,000 per complication, the financial case for pre-operative risk intelligence is overwhelming, even before considering patient outcomes.
A frank assessment of what current AI tools can and cannot do in the operating room, and where the genuine clinical opportunity lies.
Quality reporting requirements are not going away. Here is how forward-thinking anesthesiology departments are automating MACRA/MIPS compliance and recovering CMS incentive payments.
The ASA Physical Status classification has served its purpose for decades. Here is why a patient-specific, multi-dimensional score is now clinically and technically feasible.
A credible perioperative AI pilot needs more than a vague promise of better outcomes. Here is what a 50-case evaluation should measure from workflow fit to finance-ready proof.